GH Research
GHRS
NASDAQ
IPO2021
about GHRS
GH Research provides clinical trial support and research services focused on developing innovative medicines for cancer and rare disease treatments.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $16.02 | $16.19 | $13.50 | $958.97M | 861.11K |